As a representative of a pharmaceutical company, you have been asked to speak to a group of physicians at a medical conference to introduce a new drug. When discussing how the drug works, which strategy is not appropriate?

A) Using complex medical terminology to define the drugs effects
B) Presenting information about the reasons the government approved the drug
C) Using results of a report on hospital administrators' responses to the case study
D) Presenting detailed graphs to show the drug's effects on patients in case studies